Chemical Structure : ATI-2173
货号: PC-38561Not For Human Use, Lab Use Only.
ATI-2173 is a novel liver-targeted prodrug of clevudine, ATI-2173 is a selective inhibitor of HBV with EC50 of 1.31 nM in primary human hepatocytes with minimal to no toxicity.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
	ATI-2173 is a novel liver-targeted prodrug of clevudine, ATI-2173 is a selective inhibitor of HBV with EC50 of 1.31 nM in primary human hepatocytes with minimal to no toxicity.
	ATI-2173 is converted to the active 5′-triphosphate in hepatocytes.
	ATI-2173 showed similar activity across HBV genotypes A, B, C, D, E, F, G, and H (EC50 of 212 nM to 718 nM) in HepG2 assays.
	ATI-2173 activity was decreased by viral polymerase mutations associated with entecavir, lamivudine, and adefovir resistance, but not capsid inhibitor resistance mutations.
	ATI-2173 demonstrated 82% hepatic extraction, no food effect, and greatly reduced peripheral exposure of clevudine compared with equimolar oral dosing of clevudine.
| 分子量 | 529.458 | |
| 分子式 | C22H29FN3O9P | |
| 外观性状 | Solid | |
| 储存条件 | 
                            
  | 
                        
                            
  | 
                    
| Solubility | 
                             10 mM in DMSO  | 
                    |
1. Squires KE, et al. Antimicrob Agents Chemother. 2020 Aug 20;64(9):e00836-20.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright